News | March 12, 2024
AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The investment will catalyse various components of the IndiaAI Mission
The validations confirm the completion of the applications and commence the scientific review process
Acquisition of exclusive commercialization rights for European markets
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Subscribe To Our Newsletter & Stay Updated
